Hyperglycemia in hospitalised patients has been linked to an increased risk of infection, a prolonged hospital stay, and a higher fatality rate. It is a common occurrence in view of the effect patients and is most likely connected to exogenous and endogenous catecholamine production caused by surgery, immunosuppression, and, in certain circumstances, diabetes mellitus. And although studies on patient populations with kidney transfusion and liver transplant (LT) demonstrate that those who present with peri - operative and postsurgical hyperglycemia have a higher rate of acute rejection as well as associated illnesses, other groups have found no benefit from strict glycemic control in LT patients. Numerous studies have shown that hyperglycemia has a predictive importance in the outcome of SARS-CoV-2 infection. A variety of processes have been hypothesised as probable drivers of this connection, but until recently they were based on hypothesis rather than investigative data. Recently, it has been discovered that the evolution of insulin resistance in the context of COVID-19 is most likely the driving factor behind the onset of overt hyperglycemia.

It is caused by an infectious insult to the adipose tissue and is accompanied with abnormal adipokine production with human adipocytes, such as reduced adiponectin, in addition to a shift toward a systemic immune secretory profile. These findings might have a significant impact not only on the treatment of hyperglycemia during infection, but also on the general knowledge of the aetiology of severe COVID-19.

Diabetes Mellitus (T1DM) is regarded as an autoimmune condition caused by defective adaptive immune responses against insulin-producing cells in the pancreas, mostly via T-cell driven mechanisms. Nonetheless, the existence of several islet autoantibodies, rather than a particular antibody, is regarded to be more predictive of T1DM development. According to research on newborns with numerous autoantibodies, the probability of improving clinical hyperglycemia at 5, 10, and 15 years is predicted to be 44%, 70%, and 84%, respectively. Trial Net data, which analysed over 180,000 relatives of T1DM patients, corroborated the extraordinarily high incidence of T1DM among families with multiple autoantibodies.

The rate of development from the presence of autoimmunity to clinically overt diabetes, in instance, has been estimated to be 10% to 12% each year. C-peptide preservation has been linked to better glycemic management and fewer complications in patients with clinically obvious diabetes. Indeed, the Diabetes Management and Problems Trial/Epidemiology of Diabetic Interventions and Complications (DCCT/EDIC) research found that stringent glucose control offers long-term advantages, including a reduction in micro/macrovascular complications. Thus, even short-term C-peptide preservation appears helpful in this setting.

Sodi-Pallares began intravenous injection of the glucose-insulin-potassium (GIK) or GIK solution in patients suffering from acute myocardial infarction (AMI) on the theory that this treatment would force potassium with glucose into the injured myocardium cells under the action of insulin. He felt that doing so would cause the injured myocardium to repolarize, preserving its survival and function. Despite the fact that this regime has been employed infrequently and unpredictably for more than 40 years, the effects have been generally unreliable. A similar GIK regimen was employed to reduce blood free fatty concentrations, which are thought to be biologically hazardous to tissue in general and the ischemic myocardium in specific. Despite the decrease in free fatty concentrations, this method was unable to enhance clinical outcomes.

Applied Microbiology: Open Access follows Editorial Tracking System for quality in peer review process. Editorial Tracking is an online manuscript submission, review and tracking systems used by most of the best open access journals. The Journal Applied Microbiology: Open Access accepts articles in the form of research articles, review articles, short communications, letter to editors, commentaries, case reports, etc. This Microbiology journal is a peer reviewed open access scholarly journal dedicated towards distribution of valuable information for the societal benefit.

Thanks and Regards

John Kimberly

Applied Microbiology: Open Access